This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its unique structure, featuring a spirocyclopropane-indene moiety, makes it a valuable intermediate in the design of molecules targeting central nervous system disorders. Researchers explore its potential as a precursor for developing drugs that modulate neurotransmitter systems, such as serotonin or dopamine receptors, which are implicated in conditions like depression, anxiety, and Parkinson's disease. Additionally, its chemical framework is of interest in medicinal chemistry for creating compounds with enhanced bioavailability and metabolic stability. The hydrochloride salt form improves its solubility, facilitating its use in experimental formulations and preclinical studies.